GlaxoSmithKline has failed to gain approval from the Food and Drug Administration for an extended release version of its epilepsy drug Lamictal, according to Bloomberg.com. Newspaper links Pittsburgh pharmacy industry to change in prescription policy Pharmacist shortage in mind, NACDS backs graduation bill Zactima-docetaxel combo can prolong lung cancer survival rates House debates bill on user fee to fund additional inspectors Medicare says it will not reverse decision to cut anemia drug reimbursements FDA bill currently in consideration to regulate prescription drug advertising NACDS' Industry Profile reports on retail pharmacy numbers Ratio works on painless drug administration device GSK licenses reverse genetics from MedImmune for flu vaccines First Previous 2676 2677 2678 2679 2680 Next Last